21784736

Villarroel C

2011

Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone.

21787970

Pories WJ

2011

The surgical treatment of type two diabetes mellitus.

21791966

Sahin I

2012

Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.

21792664

Dolfin E

2011

FSH-receptor Ala307Thr polymorphism is associated to polycystic ovary syndrome and to a higher responsiveness to exogenous FSH in Italian women.

21793282

Skampardonis N

2011

Marked hyperandrogenemia and acne associated with polycystic ovaries in Greek women with polycystic ovary syndrome.

21793705

Grodnitskaya EE

2012

Homocysteine metabolism in polycystic ovary syndrome.

21795737

Fauser BC

2011

Sex steroid hormones and reproductive disorders: impact on women's health.

21798960

Rab?l R

2011

Skeletal muscle mitochondrial function in polycystic ovarian syndrome.

21801267

Lin YS

2011

Interleukin-6 as an early chronic inflammatory marker in polycystic ovary syndrome with insulin receptor substrate-2 polymorphism.

21803406

Rizzo A

2011

In vivo and in vitro studies of the role of the adrenergic system and follicular wall contractility in the pathogenesis and resolution of bovine follicular cysts.

21803757

Valkenburg O

2011

Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.

21804500

Anwary SA

2011

Laparoscopic findings of subfertile female patients in a tertiary hospital.

21805145

Matevosyan NR

2011

Schizophrenia and Stein-Leventhal syndrome: comorbidity features.

21805747

Guo JY

2011

[The relationship between nonalcoholic fatty liver disease and polycystic ovarian syndrome].

21807013

Lecke SB

2011

CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome.

21810946

Wilson-P?rez HE

2011

The effect of vertical sleeve gastrectomy on a rat model of polycystic ovarian syndrome.

21811536

Kaya MK

2011

A case of vogt-koyanagi-harada disease associated with polycystic ovary syndrome.

21812223

Mouraux T

2010

[(Pre)type 2 diabetes and MODY: pediatric diabetology future].

21813121

Hurd WW

2011

Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.

21815904

Xu X

2012

Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes.

21816787

Pastore LM

2011

True and sham acupuncture produced similar frequency of ovulation and improved LH to FSH ratios in women with polycystic ovary syndrome.

21819988

Feng Y

2011

Effects of androgen and leptin on behavioral and cellular responses in female rats.

21820653

Coste O

2011

Polycystic ovary-like syndrome in adolescent competitive swimmers.

21820654

Detti L

2011

Fetal reduction for hyperreactio luteinalis.

21820873

Hu X

2011

A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.

21820924

Shen Y

2011

Evaluation of the association between GHR exon 3 polymorphism and polycystic ovary syndrome among Han Chinese women.

21824047

Ramos Cirilo PD

2012

Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome.

21825025

Wenner MM

2011

Endothelin B receptor contribution to peripheral microvascular function in women with polycystic ovary syndrome.

21827375

Bidzi?ska-Speichert B

2012

Pro12Ala PPAR ?2 gene polymorphism in PCOS women: the role of compounds regulating satiety.

21830009

Doll I

2012

Diagnosis and therapy of polycystic ovarian syndrome: results of a survey among German gynecologists with a review on literature.

21830453

Kasum M

2010

Treatment of ovarian hyperstimulation syndrome: new insights.

21831351

Bhagavath B

2012

Ovulation induction in women with polycystic ovary syndrome: an update.

21831503

Badawy A

2011

Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS: a prospective randomized trial.

21831508

Oner G

2011

Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.

21832111

Aubuchon M

2011

Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome.

21833961

Lim DC

2011

Acupuncture for polycystic ovarian syndrome.

21835833

Williams RM

2012

Premature adrenarche.

21838163

Li S

2011

A logistic regression analysis of factors related to the treatment compliance of infertile patients with polycystic ovary syndrome.

21839435

Grynberg M

2011

Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected in women presenting with severe ovarian hyperstimulation syndrome.

21839436

Jatzko B

2011

Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis.

21840540

Sundaram SS

2011

What do ovaries have to do with sleeping?

21840744

Mayenga JM

2011

[The place of ovarian drilling in the management of polycystic ovarian syndrome (PCOS)].

21840745

Catteau-Jonard S

2011

[Anti-Mullerian hormone and polycystic ovary syndrome].

21840905

Seow KM

2011

Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary syndrome.

21842175

Shokeir T

2011

Laparoscopic ovarian diathermy after clomiphene failure in polycystic ovary syndrome: is it worthwhile? A randomized controlled trial.

21845803

Carlomagno G

2011

Inositol safety: clinical evidences.

21846454

Green JA

2011

Is there a place for AMH testing in Canada?

21848022

Brannian JD

2011

Obesity and fertility.

21849061

Gleicher N

2011

The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?

21849297

Loh JS

2011

Anti-Mullerian hormone--is it a crystal ball for predicting ovarian ageing?

21851420

Kim JJ

2011

Association of polycystic ovarian syndrome with human leukocyte antigen polymorphism in Korean women.

21851939

Wallace KL

2011

Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome.

21853931

Bidzi?ska-Speichert B

2011

Pro12Ala PPAR gamma2 gene polymorphism in women with polycystic ovary syndrome.

21853932

Banaszewska B

2011

[The influence of low-dose oral contraceptive pill on clinical and metabolic parameters in young women with polycystic ovary syndrome].

21856600

Paparodis R

2011

The Hirsute woman: challenges in evaluation and management.

21862266

Oghan F

2012

Does hyperandrogenism have an effect on hearing loss in patients with polycystic ovary syndrome?

21864293

Mendoza N

2011

Common genetic aspects between polycystic ovary syndrome and diabetes mellitus.

21865358

Banaszewska B

2011

Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.

21865408

Choi JH

2011

Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.

21866332

Kachuei M

2012

Prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.

21866657

Zhao H

2011

[Correlation between Chinese medicine syndrome types of polycystic ovary syndrome and ovulation induction effect].

21868003

De Vos M

2011

Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome.

21872228

Hudecova M

2011

Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.

21877021

Romano LG

2011

[Metabolic abnormalities in polycystic ovary syndrome women: obese and non obese].

21880273

Lessey BA

2011

Assessment of endometrial receptivity.

21880276

Holte J

2011

Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries.

21880803

Lass N

2011

Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls.

21883348

Isik S

2012

Impaired gallbladder motility and the effect of metformin therapy in patients with polycystic ovary syndrome.

21894688

Cui W

2011

[Effect of electroacupuncture on oocyte quality and pregnancy for patients with PCOS undergoing in vitro fertilization and embryo transfervitro fertilization and embryo transfer].

21895045

G?mez V?zquez M

2011

Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders.

21896560

Fauser BC

2011

Contemporary genetic technologies and female reproduction.

21898634

Zueff LF

2012

Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.

21899727

Geller DH

2011

State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

21906115

Huang M

2012

Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis.

21906521

Kuek S

2011

Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.

21908093

Xiong YL

2011

Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome.

21908468

Rosenfield RL

2011

Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.

21909749

Guzel AI

2012

Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome.

21910062

Park JJ

2011

Induction of secretory leukocyte protease inhibitor (SLPI) in estradiol valerate (EV) induced polycystic ovary.

21910085

Aerts JM

2011

Glycosphingolipids and insulin resistance.

21910337

Li XP

2011

[Therapeutic efficacy of modified zigui decoction in treatment of polycystic ovary syndrome of gan-shen yin deficiency syndrome].

21910340

Wang XJ

2011

[Study on the correlation between different Chinese medicine syndrome types and endocrine metabolism of polycystic ovarian syndrome].

21911106

Pastore LM

2011

Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women.

21913913

Lajunen TK

2012

Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome.

21913952

Weickert MO

2012

Improved gall bladder motility in PCOS women treated with metformin--interaction of free fatty acids with circulating cholecystokinin?

21916294

Stiefelhagen P

2011

[Endocrine causes in obesity: when are are the glands really responsible?].

21916800

Makker A

2012

PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update.

21917254

Palomba S

2011

Does metformin affect the ovarian response to gonadotropins for in?vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.

21918126

Ortega I

2012

Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells.

21920943

Ketel IJ

2011

Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS.

21926054

Dewailly D

2011

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

21926055

Raine-Fenning N

2011

What's in a number? The polycystic ovary revisited.

21926412

Liang SJ

2011

Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40.

21926952

Ciotta L

2011

[Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease].

21929505

Teede HJ

2011

Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline.

21932178

Tomova A

2011

Anti-M?llerian hormone in women with polycystic ovary syndrome before and after therapy with metformin.

21934452

Dmitrovic R

2011

Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome.

21935484

Hogg K

2011

The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep.

21936341

Maciejewska-Jeske M

2011

[C-peptide and its role in the physiology and chosen endocrinopathies].

21937505

Lerchbaum E

2011

Fatty liver index in polycystic ovary syndrome.